| __timestamp | Apellis Pharmaceuticals, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 2908166 | 31073000 |
| Thursday, January 1, 2015 | 6356782 | 43216000 |
| Friday, January 1, 2016 | 4303743 | 50679000 |
| Sunday, January 1, 2017 | 10463151 | 79171000 |
| Monday, January 1, 2018 | 22639184 | 168218000 |
| Tuesday, January 1, 2019 | 67046483 | 210796000 |
| Wednesday, January 1, 2020 | 139401000 | 203613000 |
| Friday, January 1, 2021 | 176771000 | 234273000 |
| Saturday, January 1, 2022 | 277163000 | 265784000 |
| Sunday, January 1, 2023 | 500815000 | 344501000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, effective cost management is crucial. Over the past decade, Insmed Incorporated and Apellis Pharmaceuticals, Inc. have demonstrated distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Apellis Pharmaceuticals saw a staggering increase of over 17,000% in SG&A expenses, peaking at approximately $500 million in 2023. Meanwhile, Insmed Incorporated's expenses grew by over 1,000%, reaching around $345 million in the same year. This divergence highlights Apellis's aggressive expansion strategy compared to Insmed's more measured approach. Understanding these trends offers valuable insights into each company's operational priorities and market strategies. As the biotech sector continues to evolve, monitoring such financial metrics will be key to predicting future industry leaders.
Novo Nordisk A/S and Insmed Incorporated: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of argenx SE and Insmed Incorporated
Who Optimizes SG&A Costs Better? Insmed Incorporated or Ascendis Pharma A/S
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Bio-Techne Corporation
Insmed Incorporated vs Lantheus Holdings, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Insmed Incorporated or Alkermes plc
Insmed Incorporated vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Pharming Group N.V. vs Apellis Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Apellis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Perrigo Company plc
Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared